187 related articles for article (PubMed ID: 30178598)
1. Activin subfamily peptides predict chronological age in humans.
Barrios-Silva LV; Parnell M; Shinwari ZB; Chaudhary GA; Xenofontos T; van Bekhoven A; McArthur S; Elliott BT
Physiol Rep; 2018 Sep; 6(17):e13823. PubMed ID: 30178598
[TBL] [Abstract][Full Text] [Related]
2. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.
Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T
BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L
J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014
[TBL] [Abstract][Full Text] [Related]
4. Lifelong exercise, but not short-term high-intensity interval training, increases GDF11, a marker of successful aging: a preliminary investigation.
Elliott BT; Herbert P; Sculthorpe N; Grace FM; Stratton D; Hayes LD
Physiol Rep; 2017 Jul; 5(13):. PubMed ID: 28701523
[TBL] [Abstract][Full Text] [Related]
5. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.
Rodgers BD; Eldridge JA
Endocrinology; 2015 Nov; 156(11):3885-8. PubMed ID: 26372181
[TBL] [Abstract][Full Text] [Related]
6. Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum.
Camparini L; Kollipara L; Sinagra G; Loffredo FS; Sickmann A; Shevchuk O
Proteomics; 2020 Jun; 20(11):e1900104. PubMed ID: 32104967
[TBL] [Abstract][Full Text] [Related]
7. Questions and Answers About Myostatin, GDF11, and the Aging Heart.
McNally EM
Circ Res; 2016 Jan; 118(1):6-8. PubMed ID: 26837737
[TBL] [Abstract][Full Text] [Related]
8. Relationships of GDF8 and 11 and Their Antagonists With Decline of Grip Strength Among Older Adults in the Baltimore Longitudinal Study of Aging.
Yamaguchi Y; Zhu M; Moaddel R; Palchamy E; Ferrucci L; Semba RD
J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(10):1793-1798. PubMed ID: 37235639
[TBL] [Abstract][Full Text] [Related]
9. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.
Egerman MA; Glass DJ
Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):174-183. PubMed ID: 31144559
[TBL] [Abstract][Full Text] [Related]
10. Differential antagonism of activin, myostatin and growth and differentiation factor 11 by wild-type and mutant follistatin.
Schneyer AL; Sidis Y; Gulati A; Sun JL; Keutmann H; Krasney PA
Endocrinology; 2008 Sep; 149(9):4589-95. PubMed ID: 18535106
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11.
McCoy JC; Walker RG; Murray NH; Thompson TB
J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa.
Wu Y; Qu J; Li H; Yuan H; Guo Q; Ouyang Z; Lu Q
Clin Endocrinol (Oxf); 2019 Jan; 90(1):88-93. PubMed ID: 30281844
[TBL] [Abstract][Full Text] [Related]
13. The Immateriality of Circulating GDF11.
Rodgers BD
Circ Res; 2016 May; 118(10):1472-4. PubMed ID: 27174947
[No Abstract] [Full Text] [Related]
14. Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.
Poggioli T; Vujic A; Yang P; Macias-Trevino C; Uygur A; Loffredo FS; Pancoast JR; Cho M; Goldstein J; Tandias RM; Gonzalez E; Walker RG; Thompson TB; Wagers AJ; Fong YW; Lee RT
Circ Res; 2016 Jan; 118(1):29-37. PubMed ID: 26489925
[TBL] [Abstract][Full Text] [Related]
15. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise.
Perakakis N; Mougios V; Fatouros I; Siopi A; Draganidis D; Peradze N; Ghaly W; Mantzoros CS
J Clin Endocrinol Metab; 2018 Oct; 103(10):3890-3899. PubMed ID: 30085147
[TBL] [Abstract][Full Text] [Related]
16. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?
Harper SC; Brack A; MacDonnell S; Franti M; Olwin BB; Bailey BA; Rudnicki MA; Houser SR
Circ Res; 2016 Apr; 118(7):1143-50; discussion 1150. PubMed ID: 27034276
[TBL] [Abstract][Full Text] [Related]
17. Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease.
Schafer MJ; Atkinson EJ; Vanderboom PM; Kotajarvi B; White TA; Moore MM; Bruce CJ; Greason KL; Suri RM; Khosla S; Miller JD; Bergen HR; LeBrasseur NK
Cell Metab; 2016 Jun; 23(6):1207-1215. PubMed ID: 27304512
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT
Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275
[TBL] [Abstract][Full Text] [Related]
19. The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men.
Bagheri R; Moghadam BH; Church DD; Tinsley GM; Eskandari M; Moghadam BH; Motevalli MS; Baker JS; Robergs RA; Wong A
Exp Gerontol; 2020 May; 133():110869. PubMed ID: 32035222
[TBL] [Abstract][Full Text] [Related]
20. A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.
Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Moaddel R; Geng-Spyropoulos M; Ferrucci L
Proteomics; 2017 Aug; 17(15-16):. PubMed ID: 28508553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
